Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/23/26 16:31 | 1/21/26 | RVMD | Health | BioPrd | Biological Products, (No Diag | Cislini Jeff | CA | O | GC | 3 | S.d | -1,250 | 73.63 | 0 | -17 | 50 | D | |||||||||||||||
1/9/26 16:20 | 1/7/26 | RVMD | Health | BioPrd | Biological Products, (No Diag | Horn Margaret A | CA | O | COO | 2 | S.d | -7,914 | 99.12 | 0 | -80 | 141 | D | |||||||||||||||
1/9/26 16:20 | 1/7/26 | RVMD | Health | BioPrd | Biological Products, (No Diag | Anders Jack | CA | O | CFO | 4 | S.d | -2,260 | 79.24 | 0 | -29 | 111 | D | |||||||||||||||
12/18/25 16:17 | 12/16/25 | RVMD | Health | BioPrd | Biological Products, (No Diag | Goldsmith Mark A | CA | DO | See Rema | 5 | S.d | -10,656 | 70.38 | 0 | -151 | 959 | D | |||||||||||||||
12/18/25 16:16 | 12/16/25 | RVMD | Health | BioPrd | Biological Products, (No Diag | Kelsey Stephen Michael | CA | O | See Rema | 1 | S | -418 | 76.82 | 0 | -5 | 279 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |